<dd id='k6dk3'><tbody id='k6dk3'><td id='k6dk3'><optgroup id='k6dk3'><strong id='k6dk3'></strong></optgroup><address id='k6dk3'><ul id='k6dk3'></ul></address><big id='k6dk3'></big></td><table id='k6dk3'></table></tbody><pre id='k6dk3'></pre></dd><span id='k6dk3'><b id='k6dk3'></b></span>
<dfn id='k6dk3'><optgroup id='k6dk3'></optgroup></dfn><tfoot id='k6dk3'><bdo id='k6dk3'><div id='k6dk3'></div><i id='k6dk3'><dt id='k6dk3'></dt></i></bdo></tfoot>
<ul id='k6dk3'></ul>
<fieldset id='k6dk3'></fieldset>
記者從歐普康視獲悉，由公司自研的用于兒童青少年近視防控的0.01%硫酸阿托品滴眼液已在7月4日作為院內制劑正式上市。據悉，其硫酸阿托品滴眼液配備了“滴眼液支架”，可方便用戶將硫酸阿托品滴眼液準確滴入眼內。
<option id='k6dk3'></option><select id='k6dk3'><span id='k6dk3'><form id='k6dk3'></form></span><dd id='k6dk3'></dd></select><dt id='k6dk3'></dt><style id='k6dk3'><big id='k6dk3'><i id='k6dk3'></i><tbody id='k6dk3'></tbody></big></style><abbr id='k6dk3'></abbr>
